Table 2 Estimated crude and adjusted incidence rate reduction of covid-19-related hospitalization for each exposure.
Immunity status | Person-days of follow-up | Events | Incidence rate | Crude estimatea | Adjusted estimatea |
---|---|---|---|---|---|
Non-recent vaccine immunity (≥5 months from Second Vaccine) | 72,914,787 | 766 | 0.0000105 | Reference | |
Boosted vaccine immunity | 143,612,328 | 213 | 0.0000015 | 86% (84–88%) | 89% (87–91%) |
Infection-induced immunity | 9,759,128 | 26 | 0.0000027 | 75% (63–83%) | 66% (50–77%) |
Enhanced infection-induced immunity | 9,266,031 | 22 | 0.0000024 | 77% (65–85%) | 75% (61–83%) |